Not a good buy right now: price is extended (RSI 79) and sitting at/near first resistance (250.55), which skews near-term risk to a pullback.
No Intellectia edge today (no AI Stock Picker / SwingMax signals), so there’s no strong timing trigger to justify chasing strength.
Fundamentals in the latest reported quarter (2025/Q3) weakened YoY (revenue, EPS, margins all down), limiting conviction for an immediate entry.
Hedge funds are aggressively buying (reported +30791% QoQ), which is a supportive backdrop, but it’s not enough to offset the current overbought/near-resistance setup for an impatient entry.
With earnings on 2026-02-09 (pre-market), event risk is approaching; without a clear bullish catalyst, the better stance is to hold/avoid initiating right here.
Technical Analysis
Trend: Bullish structure with moving averages aligned positively (SMA_5 > SMA_20 > SMA_200), indicating an uptrend.
Momentum: MACD histogram +0.536 and expanding above zero = bullish momentum remains.
Overbought/extension: RSI_6 at ~79 suggests the move is stretched and vulnerable to a short-term cooldown.
Key levels: Pivot ~243.27; Support S1 ~235.98 (S2 ~231.48). Resistance R1 ~250.55 (price ~250.54 essentially at R1) and R2 ~255.05.
Pattern-based projection: Similar-pattern stats imply ~+2.1% next week but ~-4.27% over the next month, reinforcing “near-term pop possible, but risk of retracement grows.”
Strong technical uptrend (bullish MA stack + positive/expanding MACD).
Hedge funds are buying aggressively (reported buying amount up 30791.40% over the last quarter).
Upcoming earnings (2026-02-09 pre-market) can act as a catalyst if results/forward commentary beat expectations (EPS est. 3.02).
Neutral/Negative Catalysts
while price is pinned at first resistance (~250.55), increasing odds of a near-term pullback.
showed YoY declines in revenue, net income, EPS, and gross margin.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 53.424M, down -4.04% YoY.
Net Income: 5.968M, down -10.63% YoY.
EPS: 1.16, down -10.77% YoY.
Gross Margin: 48.89%, down -4.88% YoY.
Summary: Growth is contracting across top line, profitability, and margins vs last year—weakening fundamental momentum.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so no clear read on recent Wall Street revisions.
Wall Street pro view (inferred from provided data only): Pros—technical trend is bullish and hedge-fund buying is strong. Cons—recent YoY financial declines and overbought/near-resistance setup reduce attractiveness for a buy “right now.”
Wall Street analysts forecast ALX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast ALX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.